Allergy affects more than one billion people worldwide—and the number is rising. For many, it means mild symptoms such as ...

An update to the guidelines for urticaria management was published, involving collaboration from various international ...

Teva’s biosimilar, PONLIMSI™, is now FDA-approved across all indications of the reference product, Prolia ® (denosumab), to treat a variety of ...

and be at least four years of age to receive neffy 1 mg dose - approval enables families of younger children wit ...

A recall of Espresso Malted Milk Balls has been elevated to the FDA’s most serious classification, raising fresh concerns ...

Biocon launches two FDA-approved interchangeable denosumab biosimilars in the US, targeting osteoporosis and bone metastasis in a $5B market.

Pixel Watch users are reporting errors in the Fitbit app following latest update These include inaccuracies with steps and calorie count, as well as mileage Neither Google nor Fitbit has addressed the ...

A WOMAN with more than 40 allergies has told how a life-changing NHS jab has helped cure them all. Chloe Ramsey, from Liss in ...

Nina Notman meets the scientists developing recombinant antivenoms and small molecule inhibitors to save the lives and limbs of snakebite patients, who number in the their hundreds of thousands ...

The modern tech office is designed to look like a seamless playground of productivity. With rows of expensive ergonomic ...

The deadline for paying the fourth and final instalment of advance tax for the financial year 2025–26 is 15 March 2026. Taxpayers must clear their advance tax dues by this date to avoid future ...

The Trump administration this week outlined a four-step tariff refund process that could be ready for companies to begin using by later this spring. The plans were included in a court filing to the US ...